Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy

Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy

US Patent 10934336 · Granted Mar 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ophthalmic topical cream compositions and methods2025
Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
Altering gene expression in cart cells and uses thereof2025
Altering gene expression in cart cells and uses thereof2025
Method and apparatus for detecting wafer cleaning anomalies2025
State monitoring method, state monitoring apparatus and state monitoring system 2025
Skin tag remover2025
Modified immune cells having enhanced function and methods for screening the sam2025
Biological active peptide for improving enzyme activity of ACE2 and application 2025
Use of gene editing to generate universal TCR re-directed t cells for adoptive i2025
Use of gene editing to generate universal TCR re-directed t cells for adoptive i2025